tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

PTC Therapeutics Inc

PTCT
Add to Watchlist
68.010USD
-7.510-9.94%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.54BMarket Cap
LossP/E TTM

PTC Therapeutics Inc

68.010
-7.510-9.94%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

PTCT Financials

See PTC Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

PTC Therapeutics Inc Earnings Date

Latest Release
Jul 30, 2026
EPS / Forecast
1.01/0.42
Revenue / Forecast
360.52M/298.96M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
1.73B
114.51%
EPS(YoY)
8.58
281.55%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
221.22%1.01
-100.31%-0.03
-92.44%-1.64
114.61%0.20
35.81%-0.83
1026.66%11.09
58.66%-0.85
21.40%-1.39
51.43%-1.29
36.48%-1.20
12.25%-2.06
---1.76
---2.66
---1.88
---2.35
---5.43
----
----
----
----
Revenue
101.55%360.52M
-76.83%272.55M
-22.75%164.68M
7.23%211.01M
-4.19%178.88M
459.73%1.18B
-30.58%213.17M
0.11%196.79M
-12.68%186.70M
-4.66%210.12M
83.41%307.06M
-9.46%196.58M
29.17%213.81M
48.17%220.38M
1.32%167.41M
56.50%217.13M
41.87%165.53M
26.11%148.74M
39.01%165.23M
17.18%138.74M
Net Profit
228.75%83.50M
-100.32%-2.81M
-104.85%-134.97M
114.90%15.90M
34.61%-64.85M
1046.28%866.56M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
34.10%-91.58M
8.83%-155.79M
-21.64%-132.97M
-30.77%-198.88M
-9.65%-138.96M
-19.28%-170.89M
18.19%-109.31M
-28.48%-152.09M
1.49%-126.73M
-92.68%-143.26M
-91.74%-133.62M
Net Margin
163.88%23.16%
-101.40%-1.03%
-165.17%-81.96%
113.90%7.53%
31.75%-36.25%
269.06%73.68%
39.08%-30.91%
19.88%-54.20%
42.89%-53.12%
30.88%-43.58%
50.30%-50.74%
---67.64%
---93.02%
---63.05%
---102.08%
---73.04%
----
----
----
----
Gross Margin
-0.17%91.19%
-13.30%85.47%
-0.78%90.10%
-4.30%88.95%
1.33%91.35%
44.00%98.58%
38.89%90.81%
42.26%92.94%
25.42%90.15%
-9.56%68.46%
-9.35%65.38%
--65.34%
--71.88%
--75.70%
--72.13%
--78.44%
----
----
----
----
Debt to assets ratio
-1.51%89.78%
0.91%91.32%
-35.87%89.73%
-30.33%90.20%
-26.83%91.16%
-24.35%90.50%
25.21%139.93%
20.28%129.48%
22.71%124.59%
42.08%119.63%
41.06%111.75%
--107.65%
--101.53%
--84.20%
--79.23%
--67.38%
----
----
----
----
Income Statement
Revenue
101.55%360.52M
-76.83%272.55M
-22.75%164.68M
7.23%211.01M
-4.19%178.88M
459.73%1.18B
-30.58%213.17M
0.11%196.79M
-12.68%186.70M
-4.66%210.12M
83.41%307.06M
-9.46%196.58M
29.17%213.81M
48.17%220.38M
1.32%167.41M
56.50%217.13M
41.87%165.53M
26.11%148.74M
39.01%165.23M
17.18%138.74M
Operating profit
527.38%148.98M
-95.27%45.89M
-414.30%-81.62M
106.71%3.49M
-4.50%-34.86M
2228.29%969.50M
-398.33%-15.87M
44.75%-51.97M
70.39%-33.36M
60.46%-45.55M
103.31%5.32M
-28.00%-94.06M
-4.72%-112.64M
-17.30%-115.22M
-65.92%-160.66M
10.68%-73.49M
-9.99%-107.56M
-0.18%-98.22M
-7.50%-96.83M
-76.06%-82.28M
Net Profit
228.75%83.50M
-100.32%-2.81M
-104.85%-134.97M
114.90%15.90M
34.61%-64.85M
1046.28%866.56M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
34.10%-91.58M
8.83%-155.79M
-21.64%-132.97M
-30.77%-198.88M
-9.65%-138.96M
-19.28%-170.89M
18.19%-109.31M
-28.48%-152.09M
1.49%-126.73M
-92.68%-143.26M
-91.74%-133.62M
Balance Sheet
Current assets
15.16%2.62B
-2.69%2.25B
66.52%2.27B
56.67%2.01B
67.38%2.27B
98.20%2.32B
12.05%1.37B
137.17%1.28B
130.27%1.36B
90.54%1.17B
75.65%1.22B
4.47%540.36M
-15.11%589.69M
-20.75%613.39M
-27.30%693.78M
-48.84%517.26M
-34.85%694.68M
-31.04%774.01M
-22.52%954.37M
-18.73%1.01B
Total current liabilities
22.82%771.07M
55.13%923.60M
66.69%968.43M
41.84%866.25M
2.95%627.81M
3.63%595.39M
-3.67%580.98M
24.10%610.71M
28.02%609.80M
30.10%574.55M
48.46%603.10M
17.15%492.12M
-16.04%476.34M
-7.37%441.63M
-20.24%406.24M
-9.71%420.08M
95.00%567.37M
89.99%476.78M
83.66%509.35M
83.30%465.26M
Total assets
23.40%3.25B
8.05%2.87B
70.01%2.90B
43.50%2.64B
37.46%2.63B
48.38%2.66B
-10.06%1.71B
46.22%1.84B
43.21%1.92B
11.24%1.79B
11.14%1.90B
-20.08%1.26B
-25.83%1.34B
-10.60%1.61B
-11.99%1.71B
-21.47%1.58B
-12.37%1.80B
-14.79%1.80B
-12.24%1.94B
-7.97%2.01B
Total liabilities
20.25%3.42B
7.34%3.05B
10.74%3.10B
-3.35%2.80B
-1.93%2.84B
5.87%2.84B
3.27%2.80B
50.03%2.90B
51.07%2.90B
29.87%2.68B
32.23%2.71B
7.06%1.93B
-3.47%1.92B
9.32%2.07B
5.99%2.05B
-5.21%1.80B
6.67%1.99B
3.89%1.89B
12.18%1.94B
13.91%1.90B
Total equity
19.94%-165.36M
2.85%-180.47M
81.30%-205.31M
85.23%-155.76M
78.93%-206.55M
79.22%-185.76M
-34.15%-1.10B
-57.18%-1.05B
-69.21%-980.18M
-95.37%-893.92M
-135.84%-818.55M
-195.64%-670.81M
-217.90%-579.27M
-405.14%-457.56M
-24236.72%-347.09M
-316.25%-226.90M
-192.70%-182.22M
-130.96%-90.58M
-99.70%1.44M
-79.46%104.93M
Cash Flow Statement
Net operating income
321.34%129.11M
-106.79%-59.04M
-14.23%-34.27M
13.89%-66.30M
18.36%-58.33M
1129.64%870.10M
70.08%-30.00M
-430.28%-76.99M
-406.04%-71.45M
339.94%70.76M
39.57%-100.29M
61.84%-14.52M
74.44%-14.12M
69.72%-29.49M
-141.09%-165.96M
25.68%-38.05M
-77.37%-55.24M
2.75%-97.40M
-6.95%-68.84M
-292.02%-51.19M
Net investment
70.96%-122.56M
49.16%-93.74M
-87.30%34.01M
-578.67%-289.62M
-540.15%-422.01M
-60.41%-184.36M
383.54%267.71M
-44.19%-42.67M
-177.55%-65.92M
-296.71%-114.93M
-391.06%-94.42M
-121.69%-29.60M
-132.87%-23.75M
-159.07%-28.97M
-52.49%32.44M
110.88%136.44M
28.89%72.25M
62.68%49.04M
132.81%68.27M
116.41%64.70M
Net financing
5249.10%211.88M
-31.96%6.40M
1042.78%302.50M
186.34%15.22M
-98.39%3.96M
1642.59%9.41M
-95.73%26.47M
-624.46%-17.63M
1235.22%246.48M
-86.81%540.00K
104.84%620.49M
102.40%3.36M
378.11%18.46M
250.51%4.09M
6857.23%302.92M
-4804.13%-140.00M
-3.86%3.86M
-87.75%1.17M
-89.14%4.35M
-99.54%2.98M

FAQs

What is the total revenue of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its total revenue reached 1.73B, with a year-on-year change of 806.78M.

What are the current assets of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its current assets were 2.27B, with a year-on-year change of 66.52.

What are the total assets of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its total assets of PTC Therapeutics Inc were 2.90B, with a year-on-year change of 70.01.

What are the total liabilities of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its total liabilities of PTC Therapeutics Inc were 3.10B, with a year-on-year change of 10.74.

What is the total equity of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its total equity of PTC Therapeutics Inc was -205.31M, with a year-on-year change of 81.30.

What is the net operating income of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its net operating income of PTC Therapeutics Inc was 856.51M, with a year-on-year change of 683.66.

What is the net investment of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its net investment of PTC Therapeutics Inc was -861.98M, with a year-on-year change of -2050.98.

What is the net financing of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its net financing of PTC Therapeutics Inc was 331.09M, with a year-on-year change of 29.40.

What is the Earnings Per Share (EPS) of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 8.58, with a year-on-year change of 281.55.

What is the net income of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its net income was 682.64M, with a year-on-year change of 287.90.

What is the net margin of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its net profit margin was 39.44, with a year-on-year change of 187.60.

What is the gross margin of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its gross margin was 95.85, with a year-on-year change of 12.30.

What is the debt-to-asset ratio of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 89.73, with a year-on-year change of -35.87.

What is the Return on Assets (ROA) of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 29.66, with a year-on-year change of 246.96.

What is the operating profit of PTC Therapeutics Inc?

According to PTC Therapeutics Inc's FY2025 earnings report, its operating profit was 856.51M, with a year-on-year change of 683.66.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy